Urgent.News

What's breaking now, across thousands of outlets.

Science

Blinatumomab improves event-free survival in children with high-risk B-cell ALL

Blinatumomab is associated with significantly higher event-free survival among children with newly diagnosed high-risk B-cell acute lymphoblastic leukemia (ALL), according to a study published in the Sept. 17 issue of the New England Journal of Medicine.

Blinatumomab improves event-free survival in children with high-risk B-cell ALL

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Science

More from Tuesday 22 September →